ATLASStarling Oncology (STLN) earnings date: Nov 5, 2026
Starling Oncology (STLN) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$0.07.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on STLN
| Last price | $6.33 (-3.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.9% |
These figures come from the same calibrated model and valuation as the Starling Oncology stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Starling Oncology reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Starling Oncology. You can switch it off at any time.
Alert me before STLN reportsFree to start. Creating an account takes under a minute.
Notify me when Starling Oncology reports
Track STLN free Add Starling Oncology to a free ATLAS watchlist and see its next report date in one place.
STLN earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.07 |
| Last report | Aug 6, 2026 · Miss |
| Average EPS surprise | -33.3% |
| Sector | Healthcare · Medical Care Facilities |
Starling Oncology earnings history: last 5 reports
Starling Oncology last reported on Aug 6, 2026: EPS of -$0.08 against an estimate of -$0.06 (-33.3% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.06 | -$0.08 | -33.3% | Miss | +27.4% |
| May 7, 2026 | -$0.09 | -$0.02 | – | – | – |
| Mar 12, 2026 | -$0.09 | -$0.06 | – | – | – |
| Nov 13, 2025 | -$0.11 | -$0.14 | – | – | – |
| Aug 13, 2025 | -$0.12 | -$0.15 | – | – | – |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for STLN
See the fair value, the probability range and the earnings history of Starling Oncology on its ATLAS page.
Starling Oncology (STLN) stock analysisPlans from €3.99 a month.
Starling Oncology earnings: frequently asked questions
When does Starling Oncology (STLN) report earnings?
Starling Oncology is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for STLN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.07 per share (USD). Estimates can change before the report.
Did Starling Oncology beat earnings estimates last quarter?
Starling Oncology last reported on Aug 6, 2026: EPS of -$0.08 against an estimate of -$0.06 (-33.3% surprise), a miss.
How much does STLN usually move in a day?
On a normal trading day the ATLAS model puts STLN’s one-day range at about ±3.9%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer